3rd Forum on Immunotherapy and Translational Immunology of Cancer (FIT-Cancer III)

Thursday, March 9 - Saturday, March 11, 2017

Presented by the Spanish Group for Immuno-Biological Therapies in Cancer (GÉTICA) in collaboration with the Society for Immunotherapy of Cancer

FIT-Cancer III is an educational program focused on facilitating the exchange of knowledge between immunologists and clinicians, to enable clinicians to integrate immunotherapies into their treatment strategy for cancer patients.

The official language of the program is Spanish. Gética is a Spanish non-profit, multi-disciplinary scientific society focused on research, education and the clinical implementation of cancer immunotherapies. Click here for more information.

SITC-Sponsored Travel Grant

Calling all Junior Faculty*! Apply for a competitive travel grant award to attend and present a poster abstract at this meeting.
*Junior Faculty are defined by the following parameters:

  • Any clinician, fellow or postdoctoral researcher involved in Oncology/Hematology/Immunology under the age of 35 years old
    OR
  • Postdoctoral researchers in Oncology/Hematology/Immunology who have not yet established themselves as independent researchers
    OR
  • Clinical staff (Oncology/Hematology/Immunology) who do not have the responsibility of leading clinical/research teams

To apply, submit an abbreviated CV (1-2 pages), letter of motivation to attend the meeting and an abstract for a poster communication to info@getica.org

  • Please write letters of motivation in Spanish. Fluency in Spanish will be required at the program.  
  • Deadline: 27 Feb 2017 at midnight Central European Time

Reduced Registration Rates for SITC members

Click here to register.

SITC members will receive discounted registration rates for this program. Check the same box that is for a discount for GETICA and SEI members.

Please email questions to info@getica.org.

Agenda

Session I: Cancer and Immune Response (I)

9:00–9:25 a.m.

Genetic and Epigenetic Aberrations in Cancer and Immune Response
Jonathan Havel*, MD, PhD – Memorial Sloan Kettering Cancer Center

9:25–9:50 a.m.

Pathologic Evaluation of Tumor Stroma
TBD

9:50–10:15 a.m.

Tumor Heterogeneity and Immune Response
Aura Muntasell, PhD – IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona

10:15–10:40 a.m.

Macrophages Polarization in Cancer
Ángel Corbí, PhD – Centro de Investigaciones Biológicas, Madrid

10:40–10:55 a.m.

Discussion

*Denotes SITC representative

Click here for full program agenda.

Location

Edificio Expo, Seville
Calle Inca Garcilaso, 3.
Isla de la Cartuja
Seville, 41092

Tags

  • Modality
  • In person event
  • User Type
  • Clinician
  • Oncologist
  • Researcher
  • Year
  • 2017
  • Source
  • Collaboration